Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 30, 2016 - Issue 4
361
Views
16
CrossRef citations to date
0
Altmetric
short communication

Apoptogenic effects of β-sitosterol glucoside from Castanopsis indica leaves

, , &
Pages 482-485 | Received 27 Dec 2014, Accepted 20 Feb 2015, Published online: 19 Mar 2015

References

  • Chen X, Bargonetti J, Prives C. 1995. p53, through p21 (WAF1/CIP1), induces cyclin D1 synthesis. Cancer Res. 55:4257–4262.
  • Das B, Mandal S, Chaudhuri K. 2014. Role of arginine, a component of aqueous garlic extract, in remediation of sodium arsenite induced toxicity in A375 cells. Toxicol Res. 3:191–196. doi:10.1039/c3tx50098e.
  • Dolai N, Karmakar I, Kumar RBS, Bala A, Majumder UK, Haldar PK. 2012. Antitumor potential of Castanopsis indica (Roxb. Ex. Lindl.) A. DC. leaf extract against Ehrlich's ascites carcinoma cell. Indian J Exp Biol. 50:359–365.
  • Helt CE, Rancourt RC, Staversky RJ, O'Reilly MA. 2001. p53-dependent induction of p21cip1/waf1/sdi1 protects against oxygen-induced toxicity. Toxicol Sci. 63:214–222. doi:10.1093/toxsci/63.2.214.
  • Rahmana SMM, Muktaa ZA, Hossain MA. 2009. Isolation and characterization of β-sitosterol-D-glycoside from petroleum extract of the leaves of Ocimum sanctum L. Asian J Food Agro-Industry. 2:39–43.
  • Yang S, Zhao Q, Xiang H, Liu M, Zhang Q, Xue W, Song B, Yang S. 2013. Antiproliferative activity and apoptosis-inducing mechanism of constituents from Toona sinesis on human cancer cells. Cancer Cell Int. 13:12–19. doi:10.1186/1475-2867-13-12.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.